Sanotize Research and Development corp.
sanotize.comTotal trials
9
Active
0
Phase 3
2
Total enrollment
2,122
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- SARS-CoV-2 Infection2
- Candidiasis, Oral1
- Recurrent Acute Rhinosinusitis1
- Verruca Plantaris1
- Chronic Sinusitis1
- Diabetic Foot Ulcer1
- Corona Virus Infection1
- SARS-CoV Infection1
Frequently asked questions about Sanotize Research and Development corp.
- How many clinical trials does Sanotize Research and Development corp. have on ClinicalTrials.gov?
- Sanotize Research and Development corp. is listed as the lead sponsor on 9 clinical trials in ClinicalTrials.gov, 0 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Sanotize Research and Development corp.'s trials are in Phase 3?
- 2 of Sanotize Research and Development corp.'s trials are in Phase 3.
- What therapeutic areas does Sanotize Research and Development corp. focus on?
- Sanotize Research and Development corp.'s most-studied conditions on ClinicalTrials.gov are SARS-CoV-2 Infection, Candidiasis, Oral, Recurrent Acute Rhinosinusitis, Verruca Plantaris, Chronic Sinusitis.